PDCD1 and melanoma: With deep tumor penetration and effective intratumor drug release, epacasome exhibited enhanced PKs and tumor accumulation in a B16-F10 melanoma model, and provided better anticancer activity, enhancing PD-1 blockage with increased CTLs and decreased Tregs and MDSCs than free EPA.